Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

37.14
Delayed Data
As of Sep 23
 -1.22 / -3.18%
Today’s Change
11.57
Today|||52-Week Range
109.18
+6.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.0013.6M0.00
 
 
Depreciation And Amortization353.0K250.0K3.9M761.0K
 
 
 
 
 
 
Operating ExpensesGross Income---250.0K9.8M-761.0K
 
 
 
 
General Expenses69.2M80.7M158.7M299.0M
 
 
 
 
 
Research And Development58.9M66.5M137.7M269.3M
 
 
 
 
 
Total Operating Expenses69.5M80.9M162.6M299.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-69.5M-80.9M-148.9M-299.8M
 
 
 
 
 
Extraordinary Credit0.000.00--24.6M
 
 
Extraordinary Charge-4.3M-2.9M-9.5M-101.6M
 
 
 
 
 
Interest Expense On Debt0.00--2.6M8.4M
 
 
 
Other Expenses-228.0K-713.0K3.3M3.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-74.0M-84.5M-157.7M-381.9M
 
 
 
 
 
Income Taxes-27.0K-52.0K-2.3M-29.1M
 
 
 
 
 
Net Income-74.0M-84.5M-160.0M-352.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.9M28.7M33.9M36.0M
 
 
 
 
 
Shares To Calculate EPS Diluted24.9M28.7M33.9M36.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.97-$2.95-$4.72-$9.79
 
 
 
 
 
EPS Diluted-$2.97-$2.95-$4.72-$9.79